Listed

Staar Surgical Co: Form 10-Q for the period ended Jun 28, 2019

Filed with the SEC on Jul 31, 2019 and accepted by EDGAR at Jul 31, 2019, 16:19 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-06-28. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2019-03-30 to 2019-06-28$5.2mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2018-12-29 to 2019-06-28$10.0mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2019-03-30 to 2019-06-28$9.8mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2018-12-29 to 2019-06-28$18.2mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2019-03-30 to 2019-06-28$29.9mus-gaap:GrossProfit
Gross profit6 months2018-12-29 to 2019-06-28$54.1mus-gaap:GrossProfit
Research and development3 months2019-03-30 to 2019-06-28$6.1mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2018-12-29 to 2019-06-28$11.7mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2019-03-30 to 2019-06-28$25.3mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2018-12-29 to 2019-06-28$47.9mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2019-03-30 to 2019-06-28$4.6mus-gaap:OperatingIncomeLoss
Operating income6 months2018-12-29 to 2019-06-28$6.2mus-gaap:OperatingIncomeLoss
Income tax3 months2019-03-30 to 2019-06-28$1.1mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2018-12-29 to 2019-06-28$1.6mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2019-03-30 to 2019-06-28$3.9mus-gaap:NetIncomeLoss
Net income6 months2018-12-29 to 2019-06-28$5.3mus-gaap:NetIncomeLoss
Diluted EPS3 months2019-03-30 to 2019-06-28$0.08us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2018-12-29 to 2019-06-28$0.11us-gaap:EarningsPerShareDiluted
Basic EPS3 months2019-03-30 to 2019-06-28$0.09us-gaap:EarningsPerShareBasic
Basic EPS6 months2018-12-29 to 2019-06-28$0.12us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2019-03-30 to 2019-06-2846,733,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2018-12-29 to 2019-06-2846,842,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2018-12-29 to 2019-06-28$4.2mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2018-12-29 to 2019-06-28$4.6mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2019-06-28$103.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-06-28$158.9mus-gaap:AssetsCurrent
Total assetsAt period end2019-06-28$186.0mus-gaap:Assets
Current liabilitiesAt period end2019-06-28$28.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2019-06-28$41.6mus-gaap:Liabilities
Shareholders' equityAt period end2019-06-28$144.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001564590-19-027498. Last ingested by Listed: Nov 4, 2026, 17:00 ET. Listed shows no prices and gives no investment advice.